Zynerba Pharmaceuticals, Inc. (ZYNE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 22.61M |
| Enterprise Value | -27.7M |
| P/E Ratio | -1.59 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.2 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.57 |
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | June 30, 2023 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.63 |
| Return On Equity | -0.59 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -34.62M |
| Net Income | -34.82M |
| Diluted EPS | -0.82 |
| Total Cash | 35.97M |
| Total Cash/Share | 1.19 |
| Total Debt | 217,879 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 5.97 |
| Book Value Per Share | 1.08 |
| 52-Week Change | 99.39 |
| 52-Week High | 1.4 |
| 52-Week Low | 0.25 |
| Moving Average 50 Days | 1.12 |
| Moving Average 200 Days | 0.61 |
| Average Volume | 1.04M |
| Shares Outstanding | 53.94M |
| % Held by Institutions | 0.03 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |